TMCnet News

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Dr. Reddy's Laboratories, Ltd. Investors
[August 23, 2017]

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Dr. Reddy's Laboratories, Ltd. Investors


Law Offices of Howard G. Smith announces an investigation on behalf of Dr. Reddy's Laboratories, Ltd. ("Dr. Reddy's" or the "Company") (NYSE: RDY) investors concerning the Company and its officers' possible violations of federal securities laws.

On November 6, 2015, Dr. Reddy's reported that the Company received a "warning letter" from the United States Food and Drug Administration ("FDA") over inadequate quality controls at three manufacturing plants producing drugs for cancer and other diseases. The Company further disclosed that it was undertaking an initiative to revamp the Company's quality controls. On this news shares of Dr. Reddy's sharply fell over several days, thereby damaging investors.



On August 10, 2017, the Company disclosed that Betapharm Arzneimittel GmbH, Germany, Dr Reddy's wholly owned subsidiary, received a communication from the Regulatory Authority of Germany (Regierung von Oberbayern) stating that the good manufacturing practices compliance certificate for the Company's formulations manufacturing Unit-2 plant was not renewed due to a recent inspection of the facility.

On this news, the Company's share price fell $1.92 per share, or 5.95%, to close at $30.33 per share on August 10, 2017.


If you purchased Dr. Reddy's securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


[ Back To TMCnet.com's Homepage ]